BetaEntity Annotation Prototype
← Back to drugs

Annotated abstract

Alzheimer’s drug lecanemab: FDA approves easier initial use, with “huge implications” for UK

bmj · 2026-07-17 · canonical JSON source

4 visible annotations · policy: published · automated confidence ≥ 75.00%

Document resource

Patients in the US are to have easier initial access to a new drug to treat Alzheimer’s disease thanks to a decision by the US Food and Drug Administration (FDA).